Vaxxinity Inc (NASDAQ:VAXX) has a beta value of 2.78 and has seen 1.97 million shares traded in the last trading session. The company, currently valued at $14.78M, closed the last trade at $0.12 per share which meant it -3.95% during that session. The VAXX stock price is -2483.33% off its 52-week high price of $3.10 and 0.0% above the 52-week low of $0.12. The 3-month trading volume is 695.47K shares.

Vaxxinity Inc (NASDAQ:VAXX) trade information

Sporting -3.95% in the red in last session, the stock has traded in the red over the last five days, when the VAXX stock price touched $0.12 or saw a rise of 58.26%. Year-to-date, Vaxxinity Inc shares have moved -86.28%, while the 5-day performance has seen it change -75.51%. Over the past 30 days, the shares of Vaxxinity Inc (NASDAQ:VAXX) have changed -83.08%.

Vaxxinity Inc (VAXX) estimates and forecasts

Figures show that Vaxxinity Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -87.62% over the past 6 months, with this year growth rate of 6.67%, compared to 12.90% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 37.50% and 33.30% for the next quarter.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -41.17% over the past 5 years.

VAXX Dividends

Vaxxinity Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.